ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts

Dewenter, Anna; Jacob, Mina A.; Cai, Mengfei; Gesierich, Benno; Hager, Paul; Kopczak, Anna; Biel, Davina; Ewers, Michael; Tuladhar, Anil M.; De Leeuw, Frank-Erik; Dichgans, Martin; Franzmeier, Nicolai; Duering, Marco*
Brain; a journal of neurology2023-2-13DOI: 10.1093/brain/awac265
25被引2阅读
引用收藏
分享

摘要

Dewenter et al. show that fixel-based analysis of diffusion MRI identifies distinct changes in white matter integrity. Neurodegeneration as a result of Alzheimer's disease is reflected in white matter macrostructure, while the effects of cerebral small vessel disease are captured in white matter microstructure. Alzheimer's disease and cerebral small vessel disease are the two leading causes of cognitive decline and dementia and coexist in most memory clinic patients. White matter damage as assessed by diffusion MRI is a key feature in both Alzheimer's and cerebral small vessel disease. However, disease-specific biomarkers of white matter alterations are missing. Recent advances in diffusion MRI operating on the fixel level (fibre population within a voxel) promise to advance our understanding of disease-related white matter alterations. Fixel-based analysis allows derivation of measures of both white matter microstructure, measured by fibre density, and macrostructure, measured by fibre-bundle cross-section. Here, we evaluated the capacity of these state-of-the-art fixel metrics to disentangle the effects of cerebral small vessel disease and Alzheimer's disease on white matter integrity. We included three independent samples (total n = 387) covering genetically defined cerebral small vessel disease and age-matched controls, the full spectrum of biomarker-confirmed Alzheimer's disease including amyloid- and tau-PET negative controls and a validation sample with presumed mixed pathology. In this cross-sectional analysis, we performed group comparisons between patients and controls and assessed associations between fixel metrics within main white matter tracts and imaging hallmarks of cerebral small vessel disease (white matter hyperintensity volume, lacune and cerebral microbleed count) and Alzheimer's disease (amyloid- and tau-PET), age and a measure of neurodegeneration (brain volume). Our results showed that (i) fibre density was reduced in genetically defined cerebral small vessel disease and strongly associated with cerebral small vessel disease imaging hallmarks, (ii) fibre-bundle cross-section was mainly associated with brain volume; and (iii) both fibre density and fibre-bundle cross-section were reduced in the presence of amyloid, but not further exacerbated by abnormal tau deposition. Fixel metrics were only weakly associated with amyloid- and tau-PET. Taken together, our results in three independent samples suggest that fibre density captures the effect of cerebral small vessel disease, while fibre-bundle cross-section is largely determined by neurodegeneration. The ability of fixel-based imaging markers to capture distinct effects on white matter integrity can propel future applications in the context of precision medicine.

学科与关键词

关键词
Alzheimer's diseasecerebral small vessel diseasefixel-based analysisdiffusion magnetic resonance imagingCADASIL
相关
加载中…
  • Multivariate network analysis of fiber tract integrity in Alzheimer's disease
    Teipel, Stefan J.*; Stahl, Robert; Dietrich, Olaf; Schoenberg, Stefan O.; Perneczky, Robert; Bokde, Arun L. W.; Reiser, Maximilian F.; Moeller, Hans-Juergen; Hampel, HaraldNeuroImage, 2007, 34(3): 985-995.被引 154
  • White matter hyperintensity microstructure in amyloid dysmetabolism
    Kalheim, Lisa F.*; Bjornerud, Atle; Fladby, Tormod; Vegge, Kjetil; Selnes, PerJournal of Cerebral Blood Flow and Metabolism, 2017, 37(1): 356-365.被引 25
  • Characterization of white matter changes along fibers by automated fiber quantification in the early stages of Alzheimer's disease
    Xin, Zhang; Yu, Sun; Weiping, Li; Bing, Liu; Wenbo, Wu; Hui, Zhao; Renyuan, Liu; Yue, Zhang; Zhenyu, Yin; Tingting, Yu; Zhao, Qing; Bin, Zhu; Yun, Xu; Zuzana, Nedelska; Jakub, Hort; Bing, ZhangNeuroImage-Clinical, 2019, 22: 101723.被引 18
查看全部 →

发表信息

论文状态
公开发表
期刊
Brain; a journal of neurology
发表日期
2023-02-13
卷期
第 146 卷, 第 2 期
页码
678-689
DOI
10.1093/brain/awac265
语言
ENGLISH
成果收录
SCIE
资助标注
European Union [666881]; DFG, Munich Cluster for Systems Neurology [390857198]; Stiftung zur Erforschung der Vaskularen Demenz; China Scholarship Council [201706100189]; Dutch Heart Foundation [2016T044]; Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; DOD ADNI [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Esai Incorporated; Elan Pharma International; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO; Janssen Alzheimer Immunotherapy Research and Development; Johnson and Johnson Pharmaceutical Research and Development; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research

作者

  • D

    Dewenter, Anna (第一作者)

  • J

    Jacob, Mina A.

查看全部 13 位作者收起作者
  • C

    Cai, Mengfei

  • G

    Gesierich, Benno

  • H

    Hager, Paul

  • K

    Kopczak, Anna

  • B

    Biel, Davina

  • E

    Ewers, Michael

  • T

    Tuladhar, Anil M.

  • D

    De Leeuw, Frank-Erik

  • D

    Dichgans, Martin

  • F

    Franzmeier, Nicolai

  • D

    Duering, Marco (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417